|Methicillin-resistant Staphylococcus aureus sequence type 239-III, Ohio, USA, 2007-2009.|
|Jump to Full Text|
|PMID: 23018025 Owner: NLM Status: MEDLINE|
|Methicillin-resistant Staphylococcus aureus (MRSA) is a human pathogen that has diverse molecular heterogeneity. Most MRSA strains in the United States are pulsed-field gel electrophoresis USA100 sequence type (ST) 5 and USA300 ST8. Infections with MRSA ST239-III are common and found during health care-associated outbreaks. However, this strain has been rarely reported in the United States. As part of a study supported by the Prevention Epicenter Program of the Centers for Disease Control and Prevention (Atlanta, GA, USA), which evaluated transmission of MRSA among hospitals in Ohio, molecular typing identified 78 (6%) of 1,286 patients with MRSA ST239-III infections. Ninety-five percent (74/78) of these infections were health care associated, and 65% (51/78) of patients had histories of invasive device use. The crude case-fatality rate was 22% (17/78). Identification of these strains, which belong to a virulent clonal group, emphasizes the need for molecular surveillance.|
|Shu-Hua Wang; Yosef Khan; Lisa Hines; José R Mediavilla; Liangfen Zhang; Liang Chen; Armando Hoet; Tammy Bannerman; Preeti Pancholi; D Ashley Robinson; Barry N Kreiswirth; Kurt B Stevenson;|
Related Documents :
|10878125 - Functional analysis of the clpatpase clpa of brucella suis, and persistence of a knocko...
401535 - Effect of amniotic fluid on bacterial growth.
20965325 - Short communication: temperature sensibility of prototheca blaschkeae strains isolated ...
23685465 - Molecular characterization of high-level gentamicin-resistant enterococcus faecalis fro...
23626845 - Strain field mapping of dislocations in a ge/si heterostructure.
16534995 - Isolation and characterization of a pseudomonas sp. that mineralizes the s-triazine her...
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.|
|Title: Emerging infectious diseases Volume: 18 ISSN: 1080-6059 ISO Abbreviation: Emerging Infect. Dis. Publication Date: 2012 Oct|
|Created Date: 2012-09-28 Completed Date: 2013-02-19 Revised Date: 2013-07-11|
Medline Journal Info:
|Nlm Unique ID: 9508155 Medline TA: Emerg Infect Dis Country: United States|
|Languages: eng Pagination: 1557-65 Citation Subset: IM|
|Ohio State University Wexner Medical Center, Columbus, Ohio 43210, USA. firstname.lastname@example.org|
|APA/MLA Format Download EndNote Download BibTex|
Aged, 80 and over
Anti-Bacterial Agents / pharmacology
Bacterial Typing Techniques
Catheterization / adverse effects
Cross Infection / epidemiology*, microbiology
Methicillin-Resistant Staphylococcus aureus / classification, drug effects, genetics*
Microbial Sensitivity Tests
Ohio / epidemiology
Renal Dialysis / adverse effects
Respiration, Artificial / adverse effects
Staphylococcal Infections / epidemiology*, microbiology
|GM080602/GM/NIGMS NIH HHS; KL2 RR02574/RR/NCRR NIH HHS; R01 GM080602/GM/NIGMS NIH HHS; U01 CI000328/CI/NCPDCID CDC HHS|
Journal ID (nlm-ta): Emerg Infect Dis
Journal ID (iso-abbrev): Emerging Infect. Dis
Journal ID (publisher-id): EID
Publisher: Centers for Disease Control and Prevention
Print publication date: Month: 10 Year: 2012
Volume: 18 Issue: 10
First Page: 1557 Last Page: 1565
PubMed Id: 23018025
Publisher Id: 12-0468
|Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–20091 Alternate Title:MRSA Sequence Type 239-III, Ohio, USA, 2007–2009|
|José R. Mediavilla|
|D. Ashley Robinson|
|Barry N. Kreiswirth|
|Kurt B. Stevenson|
|for the Prevention Epicenter Program of the Centers for Disease Control and Prevention|
|The Ohio State University Wexner Medical Center, Columbus, Ohio, USA (S.H. Wang, Y. Khan, L. Hines, A. Hoet, P. Pancholi, K.B. Stevenson);
|University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA (J.R. Mediavilla, L. Chen, B.N. Kreiswirth);
|University of Mississippi Medical Center, Jackson, Mississippi, USA (L. Zhang, D.A. Robinson);
|and The Ohio Department of Health Laboratories, Reynoldsburg, Ohio, USA (T. Bannerman)
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: September 20, 2012; Expiration date: September 20, 2013
Upon completion of this activity, participants will be able to:
- Distinguish the most common strains of methicillin-resistant Staphylococcus aureus (MRSA) in the United States
- Assess the clinical characteristics of infection with MRSA-ST239-III
- Analyze the treatment and prognosis of MRSA-ST239-III infection
- Evaluate molecular characteristics of MRSA-ST239-III.
Thomas J. Gryczan, MS, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Thomas J. Gryczan, MS, has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Shu-Hua Wang, MD, MPH; Yosef Khan, MBBS, PhD; Jose R. Mediavilla, MBS, MPH; Liangfen Zhang, MD, PhD; Liang Chen, PhD; Armando Hoet, PhD; Tammy Bannerman; D. Ashley Robinson, PhD; Barry N. Kreiswirth, PhD; and Kurt B. Stevenson, MD, MPH, have disclosed no relevant financial relationships. Lisa Hines, RN, CIC,has disclosed the following relevant financial relationships: owns stock, stock options, or bonds from Kimberly-Clark Corp., General Electric Co., Medtronic Inc., Stryker Corp., TEVA Pharmaceutical Industries. Preeti Pancholi, PhD, has disclosed the following relevant financial relationships: served as an advisor or consultant for Abbott; served as a speaker or a member of a speakers bureau for Abbott, Nanosphere; received grants for clinical research from Cepheid, Abbott, Quidel, Qiagen, Nanosphere.
Suggested citation for this article: Wang S-H, Khan Y, Hines L, Mediavilla JR, Zhang L, Chen L, et al. Methicillin-resistant Staphylococcus aureus sequence type 239-III, Ohio, USA, 2007–2009. Emerg Infect Dis [Internet]. 2012 Oct [date cited]. http://dx.doi.org/10.3201/eid1810.120468
1Presented in part at the 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, British Columbia, Canada, October 21–24, 2010.
Keywords: Keywords: Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, MRSA, MRSA ST239-III, bacteria, sequence type, virulent clones, Brazilian clone, Portuguese clone, Ohio, United States.
Previous Document: Human parvovirus 4 in nasal and fecal specimens from children, Ghana.
Next Document: Center of pressure progression characteristics under the plantar region for elderly adults.